Dimensional Fund Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-79,731
| Closed | -$1.42M | – | 3469 |
|
|
2018
Q3 | $1.42M | Hold |
79,731
| – | – | ﹤0.01% | 2992 |
|
|
2018
Q2 | $1.1M | Sell |
79,731
-5,300
| -6% | -$62.9K | ﹤0.01% | 3010 |
|
|
2018
Q1 | $773K | Hold |
85,031
| – | – | ﹤0.01% | 3044 |
|
|
2017
Q4 | $364K | Hold |
85,031
| – | – | ﹤0.01% | 3139 |
|
|
2017
Q3 | $120K | Sell |
85,031
-13,282
| -14% | -$18.5K | ﹤0.01% | 3260 |
|
|
2017
Q2 | $147K | Buy |
98,313
+25,003
| +34% | +$53.7K | ﹤0.01% | 3221 |
|
|
2017
Q1 | $188K | Buy |
73,310
+35,300
| +93% | +$81.7K | ﹤0.01% | 3208 |
|
|
2016
Q4 | $97K | Buy |
38,010
+3,700
| +11% | +$10.6K | ﹤0.01% | 3247 |
|
|
2016
Q3 | $106K | Buy |
34,310
+3,400
| +11% | +$10.6K | ﹤0.01% | 3229 |
|
|
2016
Q2 | $99K | Hold |
30,910
| – | – | ﹤0.01% | 3236 |
|
|
2016
Q1 | $96K | Hold |
30,910
| – | – | ﹤0.01% | 3237 |
|
|
2015
Q4 | $124K | Sell |
30,910
-300
| -1% | -$1.38K | ﹤0.01% | 3254 |
|
|
2015
Q3 | $143K | Sell |
31,210
-36,274
| -54% | -$190K | ﹤0.01% | 3272 |
|
|
2015
Q2 | $350K | Buy |
67,484
+2,630
| +4% | +$15.8K | ﹤0.01% | 3189 |
|
|
2015
Q1 | $406K | Buy |
64,854
+6,200
| +11% | +$35.8K | ﹤0.01% | 3141 |
|
|
2014
Q4 | $369K | Buy |
58,654
+58,354
| +19,451% | +$356K | ﹤0.01% | 3184 |
|
|
2014
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 3535 |
|
|
2014
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 3582 |
|
|
2014
Q1 | $7K | Sell |
300
-149,469
| -100% | -$2.17M | ﹤0.01% | 3558 |
|
|
2013
Q4 | $1.6M | Sell |
149,769
-54,534
| -27% | -$602K | ﹤0.01% | 2899 |
|
|
2013
Q3 | $2.72M | Sell |
204,303
-3,797
| -2% | -$60K | ﹤0.01% | 2762 |
|
|
2013
Q2 | $2.73M | Buy |
+208,100
| New | +$2.81M | ﹤0.01% | 2722 |
|
Other funds holding ECYT
Dimensional Fund Advisors's ECYT Position: Q4 2018 in Review
Dimensional Fund Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 79,731 shares — an estimated $1.42M sold.
Dimensional Fund Advisors first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $2.73M in Q2 2013. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Dimensional Fund Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Dimensional Fund Advisors sold 79,731 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.42M.
- Dimensional Fund Advisors first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
- Dimensional Fund Advisors's Endocyte, Inc. Common Stock position peaked at $2.73M in Q2 2013.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Dimensional Fund Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.